Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study

Affiliations

• ¹ School of Data Science, City University of Hong Kong, Kowloon, Hong Kong.
• ² Department of Anaesthesia and Intensive Care, Li Ka Shing Institute of Health Sciences, Hong Kong, China.
• ³ Cardiovascular Analytics Group, Laboratory of Cardiovascular Physiology, Hong Kong, China.
• ⁴ Department of Medicine, The University of Hong Kong, Hong Kong, China.
• ⁵ School of Data Science, City University of Hong Kong, Kowloon, Hong Kong [email protected] [email protected].
• ⁶ Tianjin Institute of Cardiology, Tianjin Medical University, Tianjin, China [email protected] [email protected].